NMES for Strength: What Pulse Settings Can—and Can’t—Do

Neuromuscular electrical stimulation (NMES) has a plausible job in resistance training: add muscle activation when voluntary effort falls short, especially during hard eccentric work. But the evidence does not yet tell you how much extra strength or function it delivers in older adults. A 2025 systematic review found only three randomized trials worldwide that met strict criteria for superimposed NMES during strength training in adults age 50 or older with functional decline.

That number should cool any confident protocol pitch. NMES may be a useful adjunct, particularly when high-effort training is limited by symptoms or deconditioning. It is not a proven replacement for progressive resistance training, and the available review text does not report the pooled effect sizes needed to show whether the combination beats training alone by a meaningful amount.

The central comparison has only three qualifying trials

Neves et al.'s 2025 systematic review and meta-analysis examined three approaches in adults at least 50 years old with age-related functional decline: strength training alone, NMES superimposed on voluntary contraction, and the combination of NMES plus strength training. The authors required randomized trials, at least two weeks of intervention, controlled strength-training intensity, and stimulation delivered during voluntary contraction rather than passively. They excluded therapeutic clinical applications.

Only three randomized controlled trials qualified. The review calculated Cohen's d values with 95% confidence intervals and generated forest and funnel plots, but the published text available for review does not include the results section. That means the pooled standardized effects, individual trial effects, heterogeneity, risk-of-bias ratings, and certainty assessments cannot be reported responsibly.

The absence of those numbers changes the conclusion. We can say the evidence base is sparse. We cannot say NMES plus strength training improves strength, walking ability, chair-rise performance, or any other functional endpoint by a known amount over strength training alone.

Frequency gives you a vocabulary, not an optimal setting

Neves et al. classify NMES frequencies in three tiers: low frequency below 50 Hz, medium frequency from 50 to 1,000 Hz, and high frequency or pulse-burst stimulation above 1,000 Hz. This is useful for describing protocols consistently, but it does not identify the best frequency for older adults with functional decline.

In general neuromuscular physiology, higher frequencies within the medium range can create stronger tetanic contractions while increasing fatigue. That trade-off is why a device setting cannot be judged by hertz alone. The available trials do not establish which frequency tier, session duration, or intervention length produces the best balance of contraction quality, tolerability, and functional gain.

For practical experimentation, medium frequency is a reasonable category to recognize because it is the range used to describe tetanic contractions in this framework. It is not a validated personalized prescription.

The useful intensity compromise is about movement

The most actionable parameter comes from a 2025 systematic review by Narvaez et al. on electrical stimulation combined with resistance training. Many EMS studies use the maximum intensity a participant can tolerate, often described as the maximum pain threshold. During dynamic exercise, however, that intensity can generate enough tension to restrict joint range of motion. A squat that cannot squat is not a training upgrade.

The review describes roughly 70% of the maximum pain threshold as the practical compromise for dynamic, superimposed protocols. It aims to preserve movement while still adding an electrical activation stimulus. This target is based on tolerability, not a standardized percentage of maximal voluntary contraction (%MVIC). Two people can therefore receive "70% of maximum pain threshold" and experience substantially different physiological doses.

That limitation matters most in older adults. Age-related changes in motor units and sensory tolerance may affect whether a person can repeatedly reach this intensity, but the available evidence does not establish adherence, dropout, or dose-response relationships for older cohorts specifically.

Why researchers think NMES could add something

The proposed mechanism is credible but remains a hypothesis rather than a confirmed outcome advantage. Narvaez et al. describe preferential recruitment of fast-twitch, type II motor units at submaximal voluntary force and continued type II activation during the eccentric phase of a movement. Voluntary neural drive often falls during eccentric contraction, when type II fibers may be de-recruited.

That creates a logical use case: someone who cannot generate or sustain high voluntary effort might use superimposed NMES to increase activation while still performing the movement. The mechanism does not prove that the added activation produces more muscle, strength, or independence over months. It explains why the intervention deserves better trials.

Clinical feasibility does not settle the training question

NMES has shown clinical relevance in older people whose disease limits exercise. In a blinded randomized trial of 24 older adults with mild, persistent, stable asthma, Develi et al. studied NMES added to conventional physiotherapy and rehabilitation. The study assessed muscle strength, functional capacity, and quality of life; the reported evidence note describes improved muscle strength and functional capacity with quadriceps NMES.

This is encouraging for feasibility in an older, exercise-limited population. It does not answer the central performance question for a generally healthy person lifting weights. The population had asthma, the comparator was a rehabilitation program rather than matched progressive strength training, and the available abstract does not provide enough protocol and effect-size detail to translate the result into a gym program.

Resistance training already clears the evidence bar

The adjunct must beat, or at least improve on, an intervention that already works. A 2026 meta-analysis of 12 randomized trials involving 518 older women with sarcopenia found that resistance training improved handgrip strength (standardized mean difference [SMD] 0.43, 95% CI 0.11 to 0.74), gait speed (SMD 0.37, 95% CI 0.09 to 0.64), and knee-extension strength (SMD 0.85, 95% CI 0.37 to 1.33). The review by Zhou et al. supports resistance training itself; it does not test NMES as an add-on.

Broader evidence points the same way. The 2026 American College of Sports Medicine position stand synthesized 137 systematic reviews involving more than 30,000 participants and found that resistance training improves muscle strength, size, and physical performance compared with no exercise. Training progression remains the foundation. Electrical stimulation has not earned permission to replace it.

Other add-on strategies also illustrate why the comparison matters. A 2021 review of 20 randomized trials in adults age 60 or older found that milk-protein supplementation could augment some resistance-training outcomes, though results varied by product and dose. That evidence base is larger than the superimposed-NMES literature, not proof that one adjunct is automatically better than another.

What to do with NMES now

If you want to try superimposed NMES during resistance training, use it as a measured experiment rather than a shortcut. A defensible starting point is approximately 70% of your own maximum tolerable intensity during dynamic movements, adjusted downward if it changes range of motion or exercise technique. Track the same outcomes you would use to judge any training block: load or repetitions at a fixed effort, sit-to-stand performance, gait speed where relevant, symptoms, and adherence over six to 12 weeks.

• Keep progressive resistance training as the primary intervention.
• Use stimulation during voluntary contractions rather than as a passive substitute for training.
• Prioritize safe movement quality over a higher device intensity.
• Do not infer a proven strength advantage from the three-trial evidence base.
• Seek clinical guidance before use if you have implanted electrical devices, a neurological condition, unexplained pain, or a condition that limits exercise.

NMES has a coherent rationale and a workable dynamic-intensity compromise. It does not yet have enough transparent trial data in functionally declining older adults to support claims about the size of its added benefit.

The honest verdict is narrow: NMES may help some people add activation when voluntary training is constrained, but the evidence cannot yet tell you which exact protocol produces superior long-term strength or function. Build the training program first. Then let the stimulator prove its value against your own recorded performance.